Correlation Between Day One and Eyenovia
Can any of the company-specific risk be diversified away by investing in both Day One and Eyenovia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Eyenovia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Eyenovia, you can compare the effects of market volatilities on Day One and Eyenovia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Eyenovia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Eyenovia.
Diversification Opportunities for Day One and Eyenovia
Very weak diversification
The 3 months correlation between Day and Eyenovia is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Eyenovia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eyenovia and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Eyenovia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eyenovia has no effect on the direction of Day One i.e., Day One and Eyenovia go up and down completely randomly.
Pair Corralation between Day One and Eyenovia
Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to generate 0.15 times more return on investment than Eyenovia. However, Day One Biopharmaceuticals is 6.63 times less risky than Eyenovia. It trades about -0.07 of its potential returns per unit of risk. Eyenovia is currently generating about -0.25 per unit of risk. If you would invest 1,447 in Day One Biopharmaceuticals on August 31, 2024 and sell it today you would lose (75.00) from holding Day One Biopharmaceuticals or give up 5.18% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Day One Biopharmaceuticals vs. Eyenovia
Performance |
| Timeline |
| Day One Biopharmaceu |
| Eyenovia |
Day One and Eyenovia Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Day One and Eyenovia
The main advantage of trading using opposite Day One and Eyenovia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Eyenovia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyenovia will offset losses from the drop in Eyenovia's long position.| Day One vs. X4 Pharmaceuticals | Day One vs. Inozyme Pharma | Day One vs. Acumen Pharmaceuticals | Day One vs. Mereo BioPharma Group |
| Eyenovia vs. Reviva Pharmaceuticals Holdings | Eyenovia vs. Cidara Therapeutics | Eyenovia vs. Fortress Biotech | Eyenovia vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |